Exome Asset Management LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 59 US equity positions worth $147.9m in its Q3 2024 13F filing. The largest position was LLY at 6.3% of the reported book, followed by ASND and BBIO.
What did Exome Asset Management LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 6.3% | $9.3m | 10,447 | – | |
| 2 | ASND ASCENDIS PHARMA A/S | Healthcare | 4.4% | $6.5m | 43,849 | – | |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.6% | $5.4m | 211,000 | – | |
| 4 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 3.6% | $5.3m | 120,165 | – | |
| 5 | TGTX TG THERAPEUTICS INC | Healthcare | 3.3% | $4.9m | 207,627 | – | |
| 6 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 3.2% | $4.8m | 18,700 | – | |
| 7 | CI THE CIGNA GROUP | Healthcare | 2.9% | $4.2m | 12,200 | – | |
| 8 | GILD GILEAD SCIENCES INC | Healthcare | 2.8% | $4.2m | 50,000 | – | |
| 9 | GERN GERON CORP | Healthcare | 2.8% | $4.1m | 905,126 | – | |
| 10 | BNTX BIONTECH SE | Healthcare | 2.8% | $4.1m | 34,552 | – | |
| 11 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 2.7% | $4.0m | 78,000 | – | |
| 12 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.7% | $4.0m | 174,400 | – | |
| 13 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.5% | $3.6m | 7,427 | – | |
| 14 | ONC BEIGENE LTD | Healthcare | 2.3% | $3.4m | 15,300 | – | |
| 15 | 2655787D BLUEPRINT MEDICINES CORP | 2.3% | $3.4m | 36,700 | – | ||
| 16 | GKOS GLAUKOS CORP | Healthcare | 2.3% | $3.4m | 25,857 | – | |
| 17 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 2.2% | $3.2m | 100,700 | – | ||
| 18 | IRON DISC MEDICINE INC | Healthcare | 2.1% | $3.2m | 64,516 | – | |
| 19 | CYTK CYTOKINETICS INC | Healthcare | 2.1% | $3.1m | 58,583 | – | |
| 20 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.0% | $2.9m | 66,200 | – | |
| 21 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.0% | $2.9m | 414,629 | – | |
| 22 | APLSUSD APELLIS PHARMACEUTICALS INC | 2.0% | $2.9m | 100,367 | – | ||
| 23 | RDY DR REDDYS LABS LTD | Healthcare | 1.9% | $2.9m | 36,300 | – | |
| 24 | NTRA NATERA INC | Healthcare | 1.9% | $2.9m | 22,450 | – | |
| 25 | BIIB BIOGEN INC | Healthcare | 1.7% | $2.6m | 13,317 | – | |
| 26 | INSM INSMED INC | Healthcare | 1.7% | $2.5m | 33,600 | – | |
| 27 | LEGN LEGEND BIOTECH CORP | Healthcare | 1.5% | $2.3m | 47,000 | – | |
| 28 | MERSANA THERAPEUTICS INC | 1.5% | $2.2m | 1,178,570 | – | ||
| 29 | ETNBGBP 89BIO INC | 1.5% | $2.2m | 300,600 | – | ||
| 30 | AKERO THERAPEUTICS INC | 1.5% | $2.2m | 77,100 | – | ||
| 31 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.5% | $2.2m | 138,152 | – | ||
| 32 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.5% | $2.2m | 176,600 | – | |
| 33 | AMGN AMGEN INC | Healthcare | 1.5% | $2.2m | 6,700 | – | |
| 34 | GH GUARDANT HEALTH INC | Healthcare | 1.4% | $2.1m | 89,800 | – | |
| 35 | NUVALENT INC | 1.4% | $2.0m | 19,945 | – | ||
| 36 | RVNCEUR REVANCE THERAPEUTICS INC | 1.2% | $1.8m | 347,600 | – | ||
| 37 | KURA KURA ONCOLOGY INC | Healthcare | 1.2% | $1.8m | 90,305 | – | |
| 38 | RZLT REZOLUTE INC | 1.2% | $1.7m | 352,056 | – | ||
| 39 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 1.1% | $1.7m | 149,600 | – | |
| 40 | EWTX EDGEWISE THERAPEUTICS INC | 1.1% | $1.6m | 59,900 | – | ||
| 41 | KARYOPHARM THERAPEUTICS INC | 1.0% | $1.5m | 2,000,000 | – | ||
| 42 | STAA STAAR SURGICAL CO | Healthcare | 1.0% | $1.5m | 40,800 | – | |
| 43 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.0% | $1.5m | 45,600 | – | |
| 44 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.0% | $1.5m | 196,500 | – | |
| 45 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.8% | $1.1m | 133,039 | – | |
| 46 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.7% | $1.1m | 36,344 | – | |
| 47 | ALVOTECH | 0.7% | $1.1m | 90,100 | – | ||
| 48 | QTRX QUANTERIX CORP | Healthcare | 0.6% | $952.6k | 73,501 | – | |
| 49 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.6% | $939.0k | 21,700 | – | |
| 50 | ACRV ACRIVON THERAPEUTICS INC | 0.6% | $817.3k | 116,757 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.